BAC in Patient With Alzheimer's Disease or Vascular Dementia
Status:
Withdrawn
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of BAC patients with
Alzheimer's disease or vascular dementia.The secondary objective of this study is to evaluate
the safety of BAC patients with Alzheimer's disease or vascular dementia.